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Abstract
Muscle weakness is highly prevalent during acute critical illness,
with the poor exercise performance that occurs after critical illness
being recognized as a consequence of skeletal muscles weakness.
Advanced techniques to measure peripheral muscle strength are
available, but they have limited use in the clinical setting. Simple
volitional methods to assess strength are limited because they rely
on patient motivation, which can be problematic in the critical care
setting. At present, the mechanisms that underlie skeletal muscle
wasting and weakness are poorly understood, but use of
rehabilitation early in critical illness appears to have beneficial
effects on outcome. The future direction will be to determine the
underlying mechanisms as well as developing rehabilitation
programmes during both the acute and the post critical illness
stages.
In this month’s issue of Critical Care, Truong and coworkers
[1] review the data on skeletal muscle dysfunction after acute
critical illness. Increasingly recognized, skeletal muscle
weakness can be commonplace in the intensive care unit
(ICU) setting, with a single centre study demonstrating that
25% of patients have muscle weakness [2]. In another study
of 116 patients [3], reduction in limb strength was associated
with respiratory muscle weakness and delayed weaning from
mechanical ventilation. These and other data have directed
the focus of health care in the UK onto rehabilitation after
critical illness, and guidelines by the National Institute of
Clinical Excellence (NICE) were recently published [4].
Identification and stratification of patients with ICU acquired
weakness (AW), who could benefit from rehabilitation, is of
fundamental importance. Nonvolitional assessments of
muscle strength, using such techniques as magnetic
stimulation of peripheral nerves, have provided detailed
physiological data that demonstrate significant reductions in
muscle strength [5-8]. However, availability of these objective
tools for assessment is limited outside the research
environment, and consequently they are of limited clinical
utility. Other measurements have been proposed, such as
hand grip strength, which are easier to perform, but such
volitional tests in critically ill patients are difficult to interpret,
especially if a borderline low normal result is obtained,
because this could indicate weakness, poor motivation or
inability to complete the task. Ali and colleagues [9] showed
that that handgrip strength can be a predictor of mortality,
although this could also be a reflection of critical illness
severity. A novel technique to consider that is relatively simple
and portable is the use of ultrasound to measure quadriceps
cross-sectional area as a nonvolitional surrogate marker of
quadriceps strength [10]. Although this has the potential to be
a clinical useful tool, the ability of ultrasound to measure cross-
sectional area sequentially in order to quantify muscle loss and
predict functional outcome remains unproven.
Although these data demonstrate the occurrence of ICU-AW,
there is a paucity of data that provide insight into the
pathophysiological mechanisms involved. Truong and
coworkers [1] identify risk factors that have been shown to be
associated with muscle weakness, and provide a summary of
the potential mechanisms of immobility and disuse related
muscle atrophy. Although these are rational explanations, our
current knowledge of the muscle atrophy/hypertrophy
signalling pathways and muscle proteolysis pathways are
mainly based on animal data. Human studies have revealed
dissociations between actual protein turnover and alterations
in signalling pathways that are purported to control protein
synthesis and breakdown [11,12]. Human studies within the
ICU setting are needed before we can begin to elucidate the
processes that underlie critical illness associated muscle
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loss. From this, muscle and other biomarkers could potentially
identify those patients who are at risk for major functional
limitation who would benefit the most from interventions such
as rehabilitation.
Despite our limited mechanistic knowledge, skeletal muscle
weakness has been shown to be an independent predictor of
mortality in stable patients with chronic obstructive pulmonary
disease and chronic heart failure, with rehabilitation improving
outcome [13-16]. Although exercise in these patients is often
carried out during stable periods, Truong and coworkers [1]
challenge the view that ICU patients receiving invasive
mechanical ventilation should be excluded from mobilization,
highlighting a low incidence of adverse events. However, we
must influence the culture within critical care to promote
these changes.
Recently, Schweickert and colleagues [17] demonstrated the
safety and efficacy of combined sedation holds and whole
body rehabilitation during the early stages of critical illness.
These interventions were conducted by a multidisciplinary
team in centres that did not routinely provide physical therapy
at the early stages of mechanical ventilation, demonstrating
better functional outcome at hospital discharge. As always
within the context of a clinical trial, strict exclusion criteria
preclude this study from being wholly generalizable,
especially because these data pertain only to medical ICU
patients. Despite significant differences in the delivery of
physical therapy rehabilitation services in ICUs in different
countries, these data show that critically ill patients can safely
receive early rehabilitation therapy with improved outcomes.
The next challenge is to unravel the pathophysiology of this
acquired skeletal muscle disease and to develop further
intervention strategies, including clinical trials investigating
the effects of rehabilitation after critical illness.
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